Meeder Asset Management Inc Vaxcyte, Inc. Transaction History
Meeder Asset Management Inc
- $1.48 Billion
- Q3 2024
A detailed history of Meeder Asset Management Inc transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Meeder Asset Management Inc holds 698 shares of PCVX stock, worth $59,539. This represents 0.01% of its overall portfolio holdings.
Number of Shares
698
Previous 63
1007.94%
Holding current value
$59,539
Previous $4,000
1875.0%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PCVX
# of Institutions
358Shares Held
122MCall Options Held
775KPut Options Held
433K-
Vanguard Group Inc Valley Forge, PA11.4MShares$976 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$932 Million0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$848 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$741 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$418 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $5.06B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...